This is a sample DataReady report for demonstration purposes. Start your own assessment →
Healthcare / Medtech · 11 July 2026
Apex Healthcare Systems
Overall maturity
2.0 / 5
Developing
Gaps identified
9
3 critical · 4 high
Quality score
41 / 100
highest-weighted domain
Priority actions
5
next 90 days
Your data estate
Apex Healthcare Systems is in the Developing phase of data maturity. Core clinical data systems are operational and reasonably well-structured, but the organisation lacks the data governance layer and analytical infrastructure required to use that data safely and compliantly for AI applications. The highest-priority gaps are in data governance ownership, data quality measurement, and DPDP/ABDM compliance for health data AI use.
Maturity by domain
Sector benchmark
You rank ahead of 57% of Healthcare / Medtech organisations assessed.
Anonymous, based on 21 assessments in your sector.
What to fix first
Appoint a Chief Data Officer or delegate data governance responsibility to a named senior owner with board reporting.
Implement automated data quality scoring (completeness, accuracy, timeliness) across the top 5 clinical data entities before any AI model is trained.
Complete a Health Data Impact Assessment under ABDM Health Data Management Policy for the diagnostic AI pilot within 60 days.
Establish a Data Governance Committee with clinical, legal, technology, and patient-safety representation.
Define and publish internal data classification tiers (Public / Internal / Confidential / Restricted) and apply them to all data assets within 90 days.
Findings by domain
Data Architecture & Integration
Data architecture is functional but fragmented. The EHR system provides a solid clinical foundation with HL7 FHIR support, but siloed definitions across teams and the absence of a data catalogue mean that "patient" means different things in different systems. This ambiguity flows directly into AI training data, where inconsistent entity definitions produce inconsistent model inputs. A data catalogue and canonical entity definitions are the architectural fix — not a rebuild.
Strengths
Gaps (2)
No unified data catalogue. Clinical teams, analytics teams, and operations each maintain separate definitions of key entities (patient, episode, diagnosis code) with no reconciliation.
HighFix: Deploy a data catalogue (Collibra, Atlan, or open-source DataHub). Establish canonical definitions for the top 10 business entities. Assign a data steward for each entity.
Real-time data streams from medical devices and IoT sensors are not integrated into the analytics layer. Diagnostic AI pilots are working on snapshots, not live data.
MediumFix: Evaluate a streaming ingestion layer (Cloud Pub/Sub or Kafka) for high-frequency device data. Pilot with one device type before general rollout.
Data Quality
Data quality is the most consequential gap for AI use cases. Without automated quality measurement, there is no way to know whether a model is being trained on high-quality data or on gaps and errors that will produce unreliable outputs. The historical completeness issue with pre-2020 demographic data is particularly important: training on systematically incomplete data across protected attributes will produce biased outputs that are hard to detect without explicit profiling.
Strengths
Gaps (2)
No automated data quality measurement. Completeness, accuracy, and timeliness of clinical data are not tracked systematically — quality is assessed reactively when AI model outputs are questioned.
CriticalFix: Implement a data quality framework with automated scoring across completeness, accuracy, and timeliness for the top 5 clinical entities. Set quality thresholds below which AI training data is flagged for review.
Historical patient data (pre-2020) has significant completeness gaps in demographic fields — particularly age, gender, and comorbidity records — that will systematically bias any AI model trained on it.
HighFix: Profile all training data for demographic completeness before model development. Where gaps exceed 15%, use appropriate imputation strategies documented in the model card. Flag affected models for bias testing.
Data Governance
Data governance is the foundational gap — and the easiest to close in terms of effort relative to impact. Forming a Data Governance Committee, appointing a named CDO or governance lead, and assigning stewards to the top data domains is an organisational decision, not a technology investment. It needs to happen before the diagnostic AI pilot is expanded, because every subsequent decision — about data quality thresholds, training data inclusion, model validation — requires a governance authority to own it.
Strengths
Gaps (2)
No formal data governance structure. No CDO, no data governance committee, no data steward assignments. Data quality and access decisions are made ad hoc by individual teams.
CriticalFix: Establish a Data Governance Committee within 60 days. Appoint data stewards for clinical, financial, and operational data domains. Define escalation paths for data quality disputes and access decisions.
No data classification policy. Highly sensitive health data (diagnosis, medication, genomics) is not distinguished from operational data in access or handling controls.
HighFix: Publish a data classification policy with at least 4 tiers (Public / Internal / Confidential / Restricted-Health). Apply classification tags to all data assets and enforce access controls commensurate with classification.
Privacy & Security
Privacy and security is the strongest dimension in the assessment, and genuinely above peer benchmarks for Indian healthcare organisations. The Critical gap here is not about controls — it is about process: AI training pipelines currently bypass the strong access controls that exist for clinical use, accessing identifiable patient data without de-identification. This is a pipeline design issue, not a policy issue, and it is a violation of DPDP Act provisions on data minimisation that needs to be remediated before any further model training.
Strengths
Gaps (1)
AI training pipelines access raw, identifiable patient data directly. Anonymisation or pseudonymisation is not applied before data reaches the model training environment.
CriticalFix: Implement a data de-identification step in all AI training pipelines using HIPAA Safe Harbor or ABDM-approved pseudonymisation. Validate de-identification effectiveness before the next training run.
Analytics Maturity
Analytics capability exists but is in early MLOps maturity. The data science team has delivered prototypes, which demonstrates capability. The gap is the infrastructure that makes prototypes into production-ready, auditable, reproducible systems. Ad hoc notebook-based training with no versioning is not defensible under ABDM or DPDP examination — reproducibility and audit trails are regulatory expectations for AI in healthcare, not optional engineering practices.
Strengths
Gaps (2)
No MLOps infrastructure. Models are trained in ad hoc notebook environments with no versioning, no reproducibility guarantees, and no deployment pipeline.
HighFix: Implement a minimal MLOps stack: version-controlled training pipelines, model versioning (MLflow or equivalent), and a staged deployment process with defined approvals before production.
Self-service analytics is limited to the BI team. Clinical teams cannot explore data independently, leading to long backlogs and shadow spreadsheet usage.
MediumFix: Evaluate a governed self-service analytics layer (Looker, Superset, or equivalent) that allows clinical leads to explore pre-approved, de-identified datasets without engineering involvement.
90-day remediation roadmap
The roadmap is sequenced to close the compliance-critical gaps first — particularly those that block the diagnostic AI pilot from proceeding — and then build the governance and infrastructure foundations that make the broader data programme sustainable. **Immediate (0–30 days):** De-identification pipeline for AI training data, automated data quality scoring for top 5 clinical entities, and Health Data Impact Assessment for the diagnostic pilot. These three actions resolve the most acute DPDP/ABDM compliance exposures. **Phase 2 (30–60 days):** Data Governance Committee formation, data classification policy, and data catalogue deployment. These establish the governance authority and asset visibility needed to manage data quality systematically rather than reactively. **Phase 3 (60–90 days):** MLOps infrastructure (versioning, deployment pipeline, monitoring), CDO appointment or designation, and data steward assignments for all major domains. At 90 days, Apex should be able to demonstrate to ABDM or DPDP auditors that health data used for AI training is de-identified, quality-measured, governed, and reproducibly documented — the four requirements that will define health AI compliance in India over the next 24 months.